CDH1 and breast cancer: Profoundly, miR-23a promotes TGF-β1–induced EMT and cancer metastasis in breast cancer cells by directly targeting the cytoplasmic domain of E-cadherin (CDH1) and activating WNT/β-catenin signaling [116].